Semaglutide: Systematic Review with ☸️SAIMSARA
SAIMSARA Journal · 2026
DOI: 10.62487/saimsara45190890 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift SAIMSARA Journal, 2026. Die Arbeit nennt 247 Literaturangaben.
Abstract (Originalsprache)
The aim of this systematic review is to comprehensively evaluate the diverse therapeutic applications, safety profile, and societal impact of semaglutide, synthesizing findings from recent academic literature to identify key clinical implications and future research directions. The review utilises 1454 original studies with 15874088 total participants (naïve ΣN). Semaglutide has emerged as a highly effective and versatile therapeutic agent, demonstrating significant benefits across a broad spectrum of conditions, most notably achieving a median body weight reduction of approximately 12.4% in adults with overweight or obesity. Its established efficacy in glycemic control, substantial cardiovascular and renal protective effects, and promising applications in liver and neurodegenerative diseases underscore its transformative role in modern medicine. While generally well-tolerated, the prevalence of gastrointestinal adverse events and concerns regarding equitable access remain important considerations. Future research should focus on optimizing long-term body composition outcomes and further elucidating its neuroprotective mechanisms, ensuring that the full potential of semaglutide is realized for all eligible patients.
Zitieren
APA
(2026). Semaglutide: Systematic Review with ☸️SAIMSARA. SAIMSARA Journal. https://doi.org/10.62487/saimsara45190890
Vancouver
Semaglutide: Systematic Review with ☸️SAIMSARA. SAIMSARA Journal. 2026. doi:10.62487/saimsara45190890
BibTeX
@article{euvimed2026,
title = {Semaglutide: Systematic Review with ☸️SAIMSARA},
journal = {SAIMSARA Journal},
year = {2026},
doi = {10.62487/saimsara45190890}
}
EUVIMED